/ACON
ACON Stock - Aclarion, Inc.
Healthcare|Medical - Healthcare Information ServicesNASDAQ
$6.20-2.21%
$0.14 (-2.21%) • Dec 19
48
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.3
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.63
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $6.82
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ACON
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$6.14 – $6.26
TARGET (TP)$7.13
STOP LOSS$5.70
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.43
52W High$3500.41
52W Low$5.55
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $45,724 | $75,404 | $60,444 | $60,292 | $48,652 |
| Gross Profit | $-84,043 | $-324 | $-4,854 | $-8,883 | $-17,593 |
| Gross Margin | -183.8% | -0.4% | -8.0% | -14.7% | -36.2% |
| Operating Income | $-5,513,049 | $-4,875,981 | $-5,561,568 | $-2,953,038 | $-4,477,458 |
| Net Income | $-6,992,927 | $-4,911,374 | $-7,068,593 | $-4,950,290 | $-4,635,245 |
| Net Margin | -15293.8% | -6513.4% | -11694.4% | -8210.5% | -9527.3% |
| EPS | $-7480.22 | $-79782.00 | $-177396.00 | $-120035.00 | $-110583.00 |
Company Overview
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ACONBeat Rate
14%
Last 14 quarters
Avg Surprise
-2221977.0%
EPS vs Estimate
Beats / Misses
2/12
Last 12 quarters
Latest EPS
$-2.93
Q4 2025
EPS Surprise History
Q2 24
-866468.1%
$-13865.09vs$-1.60
Q2 24
-695331.6%
$-3963.96vs$-0.57
Q3 24
-711136.8%
$-1351.35vs$-0.19
Q4 24
+16.7%
$-1351.35vs$-1621.62
Q1 25
-3003.9%
$-1551.93vs$-50.00
Q2 25
+99.4%
$-9.32vs$-1447.20
Q3 25
-21.7%
$-2.75vs$-2.26
Q4 25
-11.0%
$-2.93vs$-2.64
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 14, 2026 | $-3.60 | — | — | — |
Q4 2025 | Nov 12, 2025 | $-2.64 | $-2.93 | -11.0% | ✗ MISS |
Q3 2025 | Aug 14, 2025 | $-2.26 | $-2.75 | -21.7% | ✗ MISS |
Q2 2025 | May 15, 2025 | $-1447.20 | $-9.32 | +99.4% | ✓ BEAT |
Q1 2025 | Mar 27, 2025 | $-50.00 | $-1551.93 | -3003.9% | ✗ MISS |
Q4 2024 | Nov 14, 2024 | $-1621.62 | $-1351.35 | +16.7% | ✓ BEAT |
Q3 2024 | Aug 14, 2024 | $-0.19 | $-1351.35 | -711136.8% | ✗ MISS |
Q2 2024 | May 15, 2024 | $-0.57 | $-3963.96 | -695331.6% | ✗ MISS |
Q2 2024 | Apr 2, 2024 | $-1.60 | $-13865.09 | -866468.1% | ✗ MISS |
Q4 2023 | Nov 14, 2023 | $-13024.80 | $-17297.30 | -32.8% | ✗ MISS |
Q3 2023 | Aug 25, 2023 | $-0.09 | $-25945.95 | -28828733.3% | ✗ MISS |
Q3 2023 | Jul 3, 2023 | $-0.10 | $-0.15 | -50.0% | ✗ MISS |
Q1 2023 | Feb 27, 2023 | $-911.20 | $-24463.39 | -2584.7% | ✗ MISS |
Q4 2022 | Nov 14, 2022 | $-0.12 | $-0.21 | -75.0% | ✗ MISS |
Q3 2022 | Aug 15, 2022 | $-0.11 | $-0.49 | -345.5% | ✗ MISS |
Q2 2022 | Jun 6, 2022 | — | $-1.03 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-63211.08 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-6.58 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-1.04 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-1.15 | — | — |
Latest News
Aclarion Announces Publication Of Featured Article Tech Update In Upcoming Special Pain Issue Of The International Journal Of Spine Surgery
📈 PositiveBenzinga•Dec 4, 2025, 01:05 PM
Ascendiant Capital Maintains Buy on Aclarion, Raises Price Target to $23
📈 PositiveBenzinga•Nov 20, 2025, 10:41 AM
Aclarion Q3 EPS $(2.93) Misses $(2.62) Estimate, Sales $18.942K Miss $40.000K Estimate
📉 NegativeBenzinga•Nov 12, 2025, 01:52 PM
Aclarion Highlights Accelerating Growth, $13.3M Cash Balance, And AI-Driven Biomarker Validation Progress
📈 PositiveBenzinga•Oct 14, 2025, 10:11 AM
Aclarion Participated In The International Society Of Pain And Neuroscience Annual Meeting, Announces Use Of MR Spectroscopy For Identifying Biomarkers Of Discogenic Pain
📈 PositiveBenzinga•Oct 13, 2025, 10:21 AM
Aclarion Begins Pivotal CLARITY Trial To Test Nociscan's Impact On Chronic Low Back Pain Surgeries
📈 PositiveBenzinga•Sep 25, 2025, 10:05 AM
Ascendiant Capital Maintains Buy on Aclarion, Raises Price Target to $22
📈 PositiveBenzinga•Sep 19, 2025, 08:30 AM
Aclarion Appoints Greg Gould As CFO, Effective Immediately, Succeeding Long-time CFO John Lorbiecki, Who Has Announced His Plans To Retire
➖ NeutralBenzinga•Sep 3, 2025, 10:05 AM
Frequently Asked Questions about ACON
What is ACON's current stock price?
Aclarion, Inc. (ACON) is currently trading at $6.20 per share. The stock has moved -2.21% today.
What is the analyst price target for ACON?
No analyst price targets are currently available for this stock.
What sector is Aclarion, Inc. in?
Aclarion, Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NASDAQ exchange.
What is ACON's market cap?
Aclarion, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does ACON pay dividends?
No, Aclarion, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBFRG
Bullfrog AI Holdings, Inc. Common Stock
$1.13
Mkt Cap: $0.0B
BNBX
BNB Plus Corp.
$2.51
Mkt Cap: $0.0B
CANF
Can-Fite BioPharma Ltd.
$0.25
Mkt Cap: $0.0B
CMND
Clearmind Medicine Inc.
$2.74
Mkt Cap: $0.0B
ENSC
Ensysce Biosciences, Inc.
$1.16
Mkt Cap: $0.0B
KZIA
Kazia Therapeutics Limited
$10.87
Mkt Cap: $0.0B
MSPR
MSP Recovery, Inc.
$0.20
Mkt Cap: $0.0B
SILO
Silo Pharma, Inc.
$0.38
Mkt Cap: $0.0B
SNGX
Soligenix, Inc.
$1.38
Mkt Cap: $0.0B
TTNP
Titan Pharmaceuticals, Inc.
$2.34
Mkt Cap: $0.0B
Explore stocks similar to ACON for comparison